State Performance in Pluripotent and Adult Stem Cell Research, 2009–2016
Authors:
- 1 April 2018
- journal article
- research article
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 13 (3) , 309-320
Abstract
Aim: To examine how the geographic distribution of pluripotent and adult stem cell research publications within the USA differs from other areas of biomedical research. Materials & methods: Publication count data for pluripotent stem cell research, adult stem cell research and a comparison group representative of biomedical research more broadly were collected and analyzed for each US state from 2009 to 2016. Results: The distribution of pluripotent stem cell research differed from the other fields with overperformance in pluripotent stem cell research observed in California, as well as Wisconsin, Massachusetts, Maryland and Connecticut. Conclusion: Our analysis suggests that permissive state stem cell policy may be one of the several factors contributing to strong state performance in pluripotent stem cell research.Keywords
This publication has 39 references indexed in Scilit:
- WARF's Stem Cell Patents and Tensions between Public and Private Sector Approaches to ResearchJournal of Law, Medicine & Ethics, 2010
- Human Embryonic Stem Cell Lines and Their Use in International ResearchStem Cells, 2009
- Competitive Federalism and the Governance of Controversial SciencePublius: The Journal of Federalism, 2009
- The regulation of human embryo and stem-cell research in the United KingdomNature Reviews Molecular Cell Biology, 2008
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- The global stem cell patent landscape: implications for efficient technology transfer and commercial developmentNature Biotechnology, 2007
- Stem cell research in ChinaPhilosophical Transactions of the Royal Society B: Biological Sciences, 2007
- States, Foundations Lead the Way After Bush Vetoes Stem Cell BillScience, 2006
- Research policy and the mobility of US stem cell scientistsNature Biotechnology, 2006
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998